BMS seeks health insurance allowance for new antitumor agent

Published: 2008-01-25 06:58:00
Updated: 2008-01-25 06:58:00
BMS Korea says it plans to negotiate with the Ministry of Health and Welfare over the insurance price of its Sprycel (dasatinib), an oral inhibitor of multiple tyrosine kinases.

The company failed to reach an agreement with the National Health Insurance Corporation on the insurance price of Sp...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.